Market Place
Sourcing Support
Pacira BioSciences: Inducement Grants Under Nasdaq LR 5635(c)(4)
06 Dec 2024 //
GLOBENEWSWIRE
Pacira Awarded New U.S. Patent Covering EXPAREL Composition
03 Dec 2024 //
GLOBENEWSWIRE
Pacira Reveals 104-Week Data on PCRX-201 for Knee Osteoarthritis
14 Nov 2024 //
GLOBENEWSWIRE
Pacira Bio to Participate in Chat at 2 Upcoming Health Conferences
12 Nov 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Q3 2024 Financial Results
06 Nov 2024 //
GLOBENEWSWIRE
CMS Establishes Additional Payment for iovera in Outpatient
04 Nov 2024 //
GLOBENEWSWIRE
Pacira to Report Q3 2024 Financial Results on November 6, 2024
30 Oct 2024 //
GLOBENEWSWIRE
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
21 Oct 2024 //
GLOBENEWSWIRE
Pacira Bio Reports Inducement Grants Under Nasdaq LR 5635(C)(4)
07 Oct 2024 //
GLOBENEWSWIRE
Pacira Gets New J-Code For Exparel Starting January 2025
03 Oct 2024 //
GLOBENEWSWIRE
Pacira Announces 104-Week Data On PCRX-201 For Osteoarthritis
26 Sep 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Inducement Grants Under Nasdaq
09 Sep 2024 //
GLOBENEWSWIRE
Pacira Comments On EXPAREL Patent Litigation Ruling
09 Aug 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Second Quarter 2024 Financial Results
30 Jul 2024 //
GLOBENEWSWIRE
Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024
23 Jul 2024 //
GLOBENEWSWIRE
CMS Proposes New EXPAREL Reimbursement For Outpatient Surgery In 2025
10 Jul 2024 //
GLOBENEWSWIRE
Enforcement Report - Week of June 19, 2024
19 Jun 2024 //
FDA
Pacira To Participate In Fireside Chat At Jefferies Conference
30 May 2024 //
GLOBENEWSWIRE
Pacira $250M 2.125% Convertible Senior Notes Offering
10 May 2024 //
GLOBENEWSWIRE
Pacira $250M Convertible Senior Notes Offering
08 May 2024 //
GLOBENEWSWIRE
Pacira To Participate In Fireside Chat At RBC Healthcare Conference
07 May 2024 //
GLOBENEWSWIRE
Pacira BioSciences Q1 2024 Results, $150M Share Repurchase
07 May 2024 //
GLOBENEWSWIRE
Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024
30 Apr 2024 //
GLOBENEWSWIRE
Pacira to Participate in Fireside Chat at the 23rd Virtual Healthcare Conference
02 Apr 2024 //
GLOBENEWSWIRE
Pacira BioSciences Announces PCRX-201 Granted RMAT Designation
13 Mar 2024 //
GLOBENEWSWIRE
Pacira to Participate in Fireside Chat at the Barclays 26th Annual Conference
06 Mar 2024 //
GLOBENEWSWIRE
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Pacira to Report 2023 Financial Results on Thursday February 29, 2024
22 Feb 2024 //
GLOBENEWSWIRE
Pacira Announces Publication of Study of EXPAREL as a Sciatic Nerve Block
15 Feb 2024 //
GLOBENEWSWIRE
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
07 Feb 2024 //
GLOBENEWSWIRE
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
04 Jan 2024 //
GLOBENEWSWIRE
Pacira Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Pacira Appoints Frank D. Lee as Chief Executive Officer
21 Dec 2023 //
GLOBENEWSWIRE
Pacira Announces FDA Approval of Expanded EXPAREL Label
10 Nov 2023 //
GLOBENEWSWIRE
Pacira to Participate in Fireside Chat at Two Healthcare Conferences in November
07 Nov 2023 //
GLOBENEWSWIRE
Pacira BioSciences Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Pacira to Report Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
American Society of Anesthesiologists Announces New Industry Supporter Pacira
12 Oct 2023 //
GLOBENEWSWIRE
Pacira Bio Appoints Four New Independent Directors to its Board of Directors
10 Oct 2023 //
GLOBENEWSWIRE
American Society of Anesthesiologists & Pacira Announce Grant for Education
02 Oct 2023 //
PRESS RELEASE
Pacira BioSciences Announces Leadership Succession Plan
26 Sep 2023 //
GLOBENEWSWIRE
Pacira Bio Announces Fireside Chat at the H.C. Wainwright 25th Annual Conference
06 Sep 2023 //
GLOBENEWSWIRE
Pacira BioSciences Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
PRESS RELEASE
Pacira To Report Q2 2023 Financial Results On Wednesday August 2, 2023
26 Jul 2023 //
PRESS RELEASE
Pacira Intrinsic Value Is Potentially 26% Below Its Share Price
07 Jul 2023 //
SIMPLYWALL
Chris Christie criticises pharma ads despite ties to the industry
16 Jun 2023 //
FINANCIAL EXPRESS
Pacira BioSciences Partners with The Invited Celebrity Classic
20 Apr 2023 //
PRESS RELEASE
Pacira BioSciences Appoints Christopher Young as Chief Manufacturing Officer
19 Apr 2023 //
PRESS RELEASE
Third Circuit Court Upholds Decision To Dismiss Pacira Biosciences, Inc. Lawsuit
27 Mar 2023 //
PRESS RELEASE
Pacira Bio Announces Yvonne Greenstreet To Retire From Board Of Directors
22 Mar 2023 //
PRESS RELEASE
Pacira To Participate In Fireside Chat At Barclays Global Healthcare Conference
08 Mar 2023 //
PRESS RELEASE
Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results
28 Feb 2023 //
PRESS RELEASE
Pacira Reports Preliminary Unaudited Total Revenue For 2022 Of $666.8 Million
05 Jan 2023 //
PRESS RELEASE
Pacira To Present At The 41St Annual J.P. Morgan Healthcare Conference
04 Jan 2023 //
PRESS RELEASE
Pacira Reports Preliminary Net Product Sales of $57.5 M for November 2022
13 Dec 2022 //
PRESS RELEASE
Pacira finds knee pain hurts physically, socially and mentally
21 Nov 2022 //
FIERCEPHARMA
Pacira BioSciences reports sales of $54.9M for October
14 Nov 2022 //
SEEKING ALPHA
Pacira Biosciences To Present At Two Healthcare Conferences In November
08 Nov 2022 //
PRESS RELEASE
Pacira Biosciences Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
PRESS RELEASE
Pacira Reports Preliminary Third Quarter 2022 Revenue of $167.5 Million
13 Oct 2022 //
PRESS RELEASE
